/PRNewswire/ GlycoEra AG, a biotechnology company building a high-value pipeline of medicines based on deep expertise in protein degradation of circulating.
- Santiago Arroyo, M.D., Ph.D., appointed Chief Development Officer
- Jennifer Perry, Pharm.D., promoted to Senior Vice President, Commercial
. | April 3, 2023